Contact Us

New Stories

• Bioxyne lands $50 million two year German supply deal with ADREX

  May 12, 2026 - - Latest News

• Amplia and ANZGOG launch trial testing candidate with chemotherapy in ovarian cancer

  May 11, 2026 - - Latest News

• Neurizon Therapeutics adds seasoned industry executive to its board

  May 11, 2026 - - Latest News

• CSL signals course correction as interim CEO outlines revised outlook and major impairments

  May 11, 2026 -

• BCAL Diagnostics names new chief executive to lead commercial expansion

  May 11, 2026 -

• Moderna expands support for early career Australian mRNA researchers

  May 7, 2026 - - Latest News

• PYC Therapeutics begins repeat dose trial for PYC-003 in polycystic kidney disease

  May 7, 2026 - - Latest News